About
Omri Amirav-Drory founded biotech tools company Genome Compiler before it was acquired by Twist Bioscience, where he served as VP of Corporate Development and Innovation, giving him hands-on experience across the full TechBio lifecycle from lab tools to strategic corporate innovation. Beyond his GP role at NFX Bio, he has stepped in as acting CEO for highly futuristic TechBio ventures during incubation, bringing a company builder mindset that alternates between investor and operating leader inside very early TechBio concepts. Omri Amirav-Drory founded biotech tools company Genome Compiler before it was acquired by Twist Bioscience, where he served as VP of Corporate Development and Innovation, giving him hands-on experience across the full TechBio lifecycle from lab tools to strategic corporate innovation. Beyond his GP role at NFX Bio, he has stepped in as acting CEO for highly futuristic TechBio ventures during incubation, bringing a company builder mindset that alternates between investor and operating leader inside very early TechBio concepts.
